314 related articles for article (PubMed ID: 21951405)
1. The future of basic science research and stroke: hubris and translational stroke research.
Lyden P
Int J Stroke; 2011 Oct; 6(5):412-3. PubMed ID: 21951405
[No Abstract] [Full Text] [Related]
2. The future of stroke neurology.
van Gijn J
J Neurol; 2004 Feb; 251(2):235-9. PubMed ID: 14991364
[No Abstract] [Full Text] [Related]
3. Future directions in IAT: better studies, better selection, better timing and better techniques.
Yoo AJ; Leslie-Mazwi TM; Jovin TG
J Neurointerv Surg; 2013 May; 5 Suppl 1():i1-6. PubMed ID: 23572460
[No Abstract] [Full Text] [Related]
4. The past is the future: innovative designs in acute stroke therapy trials.
Krams M; Lees KR; Berry DA
Stroke; 2005 Jun; 36(6):1341-7. PubMed ID: 15879340
[No Abstract] [Full Text] [Related]
5. [Advanced therapy strategies in neurological diseases: present and perspectives].
Ludolph AC; Kassubek J
Nervenarzt; 2011 Aug; 82(8):955-6. PubMed ID: 21796437
[No Abstract] [Full Text] [Related]
6. Neuroprotection and stroke: time for a compromise.
Young AR; Ali C; Duretête A; Vivien D
J Neurochem; 2007 Nov; 103(4):1302-9. PubMed ID: 17727635
[TBL] [Abstract][Full Text] [Related]
7. Translating promising preclinical neuroprotective therapies to human stroke trials.
Cook DJ; Tymianski M
Expert Rev Cardiovasc Ther; 2011 Apr; 9(4):433-49. PubMed ID: 21517728
[TBL] [Abstract][Full Text] [Related]
8. Stroke management.
Gubitz G; Sandercock P
Clin Evid; 2002 Dec; (8):169-83. PubMed ID: 12603876
[No Abstract] [Full Text] [Related]
9. Stroke management.
Gubitz G; Sandercock P
Clin Evid; 2002 Jun; (7):161-74. PubMed ID: 12230642
[No Abstract] [Full Text] [Related]
10. Next steps in clinical trial redesign.
Nicholas J
J Natl Cancer Inst; 2012 Jan; 104(2):90-2. PubMed ID: 22215851
[No Abstract] [Full Text] [Related]
11. Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3.
Fisher M;
Stroke; 2003 Jun; 34(6):1539-46. PubMed ID: 12750546
[TBL] [Abstract][Full Text] [Related]
12. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
Savitz SI; Fisher M
Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989
[TBL] [Abstract][Full Text] [Related]
13. [Human, economics and social sciences: rebounds of ideas on genomics and clinical trials].
Julian-Reynier C
Med Sci (Paris); 2012 Mar; 28 Spec No 1():3-4. PubMed ID: 22494647
[No Abstract] [Full Text] [Related]
14. Recent advances in pharmacologic neuroprotection.
Mantz J; Degos V; Laigle C
Eur J Anaesthesiol; 2010 Jan; 27(1):6-10. PubMed ID: 19617840
[TBL] [Abstract][Full Text] [Related]
15. The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents.
Cramer SC; Koroshetz WJ; Finklestein SP
Stroke; 2007 Apr; 38(4):1393-5. PubMed ID: 17332455
[TBL] [Abstract][Full Text] [Related]
16. Acute stroke therapies: some unexpected challenges.
Donnan GA
Int J Stroke; 2007 Nov; 2(4):235. PubMed ID: 18705920
[No Abstract] [Full Text] [Related]
17. Update on recent progress in drug treatment for acute ischemic stroke.
Devuyst G; Bogousslavsky J
J Neurol; 2001 Sep; 248(9):735-42. PubMed ID: 11596776
[No Abstract] [Full Text] [Related]
18. Sisyphus and translational stroke research.
Lyden P; Lapchak P
Sci Transl Med; 2012 Oct; 4(156):156ps20. PubMed ID: 23076354
[TBL] [Abstract][Full Text] [Related]
19. Stroke treatment--light at the end of the tunnel?
Garber K
Nat Biotechnol; 2007 Aug; 25(8):838-40. PubMed ID: 17687351
[No Abstract] [Full Text] [Related]
20. Citicoline--the first effective neuroprotectant to be combined with thrombolysis in acute ischemic stroke?
Overgaard K; Meden P
J Neurol Sci; 2006 Sep; 247(2):119-20. PubMed ID: 16765988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
